HighTower Advisors
NUTX icon

HighTower Advisors’s Nutex Health NUTX Stock Holding History

HighTower Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.1M Buy
+5,217
New +$960K ﹤0.01% 2209

Other funds holding NUTX

Pertento Partners
Pertento Partners London, United Kingdom $2.09B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Winmill & Co
Winmill & Co Walpole, New Hampshire $404M AUM 39.18% 1-Year Est. Return
Empowered Funds
Empowered Funds Havertown, Pennsylvania $21.7B AUM 41.23% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return

HighTower Advisors's NUTX Position: Q3 2026 in Review

HighTower Advisors opened a new position in Nutex Health (NUTX) in Q3 2026: 5,217 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #2209 among its holdings.

137 funds tracked by Wall St. Rank hold NUTX as of Q3 2026.

  • HighTower Advisors held 5,217 shares of Nutex Health worth $1.1M as of Q3 2026.
  • Nutex Health was a new HighTower Advisors position in Q3 2026.
  • Nutex Health made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2209 holding.
  • 137 funds tracked by Wall St. Rank held Nutex Health as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.